Information  X 
Enter a valid email address

Company Name matching 'BioNTech SE'

Date
Time Source
Company
Announcement
25 Nov 2021 12:30 pm GNW   BioNTech SE Pfizer and BioNTech Receive Positive CHMP Opinion for COMIRNATY® in Children 5 to under 12 Years of Age in the European Union
22 Nov 2021 11:45 am GNW   BioNTech SE Follow-Up Data from Phase 3 Trial Of Pfizer-BioNTech COVID-19 Vaccine Support Safety and High Efficacy in Adolescents 12 Through 15 Years of Age
19 Nov 2021 11:30 am GNW   BioNTech SE BioNTech Receives FDA Fast Track Designation for its FixVac Candidate BNT111 in Advanced Melanoma
09 Nov 2021 11:45 am GNW   BioNTech SE BioNTech Announces Third Quarter 2021 Financial Results and Corporate Update
01 Nov 2021 12:00 pm GNW   BioNTech SE BioNTech to Present New Clinical Data from First-in-Class CAR-T Program BNT211 in Late-breaking Session at 36th SITC Annual Meeting
29 Oct 2021 10:45 pm GNW   BioNTech SE Pfizer and BioNTech Receive First U.S. FDA Emergency Use Authorization of a COVID-19 Vaccine in Children Ages 5 Through 11 Years
28 Oct 2021 11:58 am GNW   BioNTech SE Pfizer And BioNTech to Provide U.S. Government an Additional 50 Million Pediatric Doses of COVID-19 Vaccine to Support Further Preparedness for Future Needs
27 Oct 2021 12:00 pm GNW   BioNTech SE BioNTech to Report Third Quarter Financial Results and Operational Update on November 9, 2021
26 Oct 2021 1:00 pm GNW   BioNTech SE BioNTech Plans to Initiate the Construction of an mRNA Vaccine Manufacturing Facility in Africa in mid-2022
21 Oct 2021 11:45 am GNW   BioNTech SE Pfizer and BioNTech Announce Phase 3 Trial Data Showing High Efficacy of a Booster Dose of Their COVID-19 Vaccine
04 Oct 2021 5:10 pm GNW   BioNTech SE Pfizer and BioNTech Receive CHMP Positive Opinion for COVID-19 Vaccine Booster in the European Union
01 Oct 2021 1:12 pm GNW   BioNTech SE BioNTech to Present New Clinical and Preclinical Data Across Multiple Immuno-Oncology Programs at 36th SITC Annual Meeting
  7:00 am GNW   BioNTech SE BioNTech Expands Clinical Oncology Portfolio with First Patient Dosed in Phase 2 Trial of mRNA-based Individualized Immunotherapy BNT122 in Colorectal Cancer Patients
22 Sep 2021 11:02 am GNW   BioNTech SE Pfizer and BioNTech Expand Collaboration with U.S. to Provide 500 Million Additional COVID-19 Vaccine Doses at Not-For-Profit Price for Donation to Poorest Countries
20 Sep 2021 11:45 am GNW   BioNTech SE Pfizer and BioNTech Announce Positive Topline Results from Pivotal Trial of COVID-19 Vaccine in Children 5 to 11 Years
18 Sep 2021 8:40 am GNW   BioNTech SE FDA Advisory Committee Votes Unanimously in Favor of COMIRNATY® Booster for Emergency Use in People 65 and Older and Certain High-Risk Populations
27 Aug 2021 12:15 pm GNW   BioNTech SE Joint Communiqué: BioNTech Evaluates mRNA Vaccine Manufacturing Solutions in Rwanda and Senegal to Improve Long-Term Vaccine Supply
26 Aug 2021 11:46 am GNW   BioNTech SE Pfizer and BioNTech Announce Collaboration with Brazil’s Eurofarma to Manufacture COVID-19 Vaccine Doses for Latin America
25 Aug 2021 5:10 pm GNW   BioNTech SE Pfizer and BioNTech Initiate Rolling Submission of Supplemental Biologics License Application to U.S. FDA for Booster Dose of COMIRNATY® in Individuals 16 and Older
23 Aug 2021 4:55 pm GNW   BioNTech SE Pfizer-BioNTech COVID-19 Vaccine COMIRNATY® Receives Full U.S. FDA Approval for Individuals 16 Years and Older
16 Aug 2021 4:31 pm GNW   BioNTech SE Pfizer and BioNTech Announce Submission of Initial Data to U.S. FDA to Support Booster Dose of COVID-19 Vaccine
09 Aug 2021 12:00 pm GNW   BioNTech SE BioNTech Announces Second Quarter 2021 Financial Results and Corporate Update
04 Aug 2021 12:00 pm GNW   BioNTech SE BioNTech Completes Acquisition of Kite’s Neoantigen TCR Cell Therapy R&D Platform and Manufacturing Facility in Gaithersburg, Maryland
02 Aug 2021 12:00 pm GNW   BioNTech SE BioNTech to Report Second Quarter Financial Results and Operational Update on August 9, 2021
26 Jul 2021 3:00 pm GNW   BioNTech SE BioNTech Provides Update on Plans to Develop Sustainable Solutions to Address Infectious Diseases on the African Continent
23 Jul 2021 2:50 pm GNW   BioNTech SE Fighting Infectious Diseases on the African Continent
  11:45 am GNW   BioNTech SE Pfizer And BioNTech to Supply U.S. Government with an Additional 200 Million Doses of COVID-19 Vaccine to Help Meet Continued Need for Vaccine Supply in the U.S.
21 Jul 2021 12:15 pm GNW   BioNTech SE Pfizer and BioNTech Announce Collaboration with Biovac to Manufacture and Distribute COVID-19 Vaccine Doses within Africa
19 Jul 2021 1:00 pm GNW   BioNTech SE BioNTech to Acquire Kite’s Neoantigen TCR Cell Therapy R&D Platform and Manufacturing Facility in Gaithersburg, MD
18 Jun 2021 10:00 am GNW   BioNTech SE BioNTech Announces First Patient Dosed in Phase 2 Clinical Trial of mRNA-based BNT111 in Patients with Advanced Melanoma
10 Jun 2021 7:00 am GNW   BioNTech SE Pfizer and BioNTech to Provide 500 Million Doses of COVID-19 Vaccine to U.S. Government for Donation to Poorest Nations
28 May 2021 8:45 pm GNW   BioNTech SE Pfizer and BioNTech Receive First Authorization in European Union for COVID-19 Vaccine in Adolescents
21 May 2021 11:00 am GNW   BioNTech SE BioNTech Publishes First Sustainability Report and Receives “Prime” Rating by ISS ESG
20 May 2021 11:00 am GNW   BioNTech SE Pfizer and BioNTech Sign Agreement for Additional Supply to Turkey of 60 Million Doses of their COVID-19 Vaccine
  10:00 am GNW   BioNTech SE Pfizer and BioNTech to Supply the European Union with up to 1.8 Billion Additional Doses of COMIRNATY®
18 May 2021 11:00 am GNW   BioNTech SE BioNTech Broadens Management Board by Appointing Jens Holstein as CFO
11 May 2021 7:30 am GNW   BioNTech SE Pfizer and BioNTech Receive First U.S. Authorization for Emergency Use of COVID-19 Vaccine in Adolescents
10 May 2021 12:00 pm GNW   BioNTech SE BioNTech Announces First Quarter 2021 Financial Results and Corporate Update
  6:31 am GNW   BioNTech SE BioNTech to Establish Regional Headquarters for South East Asia and First mRNA Manufacturing Facility in Singapore
07 May 2021 11:45 am GNW   BioNTech SE Pfizer and BioNTech Initiate Rolling Submission of Biologics License Application for U.S. FDA Approval of their COVID-19 Vaccine
06 May 2021 11:30 am GNW   BioNTech SE Pfizer and BioNTech to Provide COVID-19 Vaccine Doses for Olympic Athletes at the 2020 Tokyo Games
04 May 2021 12:02 pm GNW   BioNTech SE BioNTech to Report First Quarter 2021 Financial Results and Operational Update on May 10, 2021
30 Apr 2021 12:00 pm GNW   BioNTech SE Pfizer and BioNTech Submit Request to Expand Conditional Marketing Authorization of COMIRNATY® in the EU to Adolescents
19 Apr 2021 9:00 am GNW   BioNTech SE Pfizer and BioNTech to Supply the European Union with 100 Million Additional Doses of COMIRNATY®
01 Apr 2021 11:45 am GNW   BioNTech SE Pfizer and BioNTech Confirm High Efficacy and No Serious Safety Concerns Through Up to Six Months Following Second Dose in Updated Topline Analysis of Landmark COVID-19 Vaccine Study
31 Mar 2021 11:45 am GNW   BioNTech SE Pfizer-BioNTech Announce Positive Topline Results of Pivotal COVID-19 Vaccine Study in Adolescents
30 Mar 2021 11:30 am GNW   BioNTech SE BioNTech Announces Full Year 2020 Financial Results and Corporate Update
26 Mar 2021 1:45 pm GNW   BioNTech SE BioNTech provides Update on Vaccine Production Status at Marburg Manufacturing Site
  1:20 pm GNW   BioNTech SE EMA Approves New Storage Option for Pfizer-BioNTech Vaccine, Easing Distribution and Storage of Doses Across European Union
23 Mar 2021 11:00 am GNW   BioNTech SE BioNTech to Report Full Year Financial Results for 2020 and Provide Corporate Update on the Fourth Quarter on March 30, 2021
11 Mar 2021 11:45 am GNW   BioNTech SE Real-World Evidence Confirms High Effectiveness of Pfizer-BioNTech COVID-19 Vaccine and Profound Public Health Impact of Vaccination One Year After Pandemic Declared
25 Feb 2021 11:45 am GNW   BioNTech SE Pfizer and BioNTech Initiate a Study as Part of Broad Development Plan to Evaluate COVID-19 Booster and New Vaccine Variants
19 Feb 2021 12:07 pm GNW   BioNTech SE Pfizer and BioNTech Submit COVID-19 Vaccine Stability Data at Standard Freezer Temperature to the U.S. FDA
18 Feb 2021 6:30 pm GNW   BioNTech SE Pfizer and BioNTech Commence Global Clinical Trial to Evaluate COVID-19 Vaccine in Pregnant Women
17 Feb 2021 10:13 pm GNW   BioNTech SE In Vitro Study Published in The New England Journal of Medicine Demonstrates Sera from Individuals Immunized with the Pfizer-BioNTech COVID-19 Vaccine Neutralize SARS-CoV-2 with South African Variant Spike Mutations
  9:00 am GNW   BioNTech SE Pfizer and BioNTech to Supply the European Union with 200 Million Additional Doses of COMIRNATY®
12 Feb 2021 1:30 pm GNW   BioNTech SE Pfizer and BioNTech to Supply the United States with 100 Million Additional Doses of COVID-19 Vaccine
10 Feb 2021 8:00 am GNW   BioNTech SE Update on vaccine production at BioNTech’s manufacturing site in Marburg
01 Feb 2021 1:32 pm GNW   BioNTech SE Pfizer and BioNTech Publish Preclinical Data from Investigational COVID-19 Vaccine Program in Nature
22 Jan 2021 5:00 pm GNW   BioNTech SE Pfizer and BioNTech Reach Agreement with COVAX for Advance Purchase of Vaccine to Help Combat COVID-19


Company Announcements Archive »


a d v e r t i s e m e n t